Publication date: October 2026 Source: Clinical Microbiology and Infection, Volume 32, Issue 10 Author(s): Jochem B. Buil, Rosalie B.T.M. Sterenborg, Paul E. Verweij, Puck Oude Elferink, Wouter A. van der Heijden, Frank L. van de Veerdonk, Roger J. Brüggemann
Funguria with severe complications in diabetic patients receiving SGLT2 inhibitors. // Clinical Microbiology and Infection. – URL: https://www.sciencedirect.com/science/article/pii/S1198743X26002077?dgcid=rss_sd_all
Funguria with severe complications in diabetic patients receiving SGLT2 inhibitors. Clinical Microbiology and Infection. https://www.sciencedirect.com/science/article/pii/S1198743X26002077?dgcid=rss_sd_all
“Funguria with severe complications in diabetic patients receiving SGLT2 inhibitors.” Clinical Microbiology and Infection.
@article{article107303,
title = {Funguria with severe complications in diabetic patients receiving SGLT2 inhibitors},
journal = {Clinical Microbiology and Infection},
url = {https://www.sciencedirect.com/science/article/pii/S1198743X26002077?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...